Steroid 5a-reductase (EC 1-3-99-5) is a NADPH dependent enzyme which converts testosterone (T) 1 into dihydrotestosterone (DHT) 2.
The essential role of 5a-reductase in prostate growth has been determined by the discovery of 5a-reductase deficiency in male pseudohermaphroditism patients who had atrophic prostate glands despite normal testosterone level. 3, 4) DHT is the most active agonist for the androgen receptor 5) although T also mediates the androgenic action in the tissues. Various steroidal compounds have been developed as 5a-reductase inhibitors for the medical therapy of BHP.
5) Finasteride 3 6) ( Fig. 1 ) a 4-aza steroid is the most extensively studied class of 5a-reductase inhibitors. 7) This compound is the first approved 5a-reductase inhibitor in the U.S.A. for the treatment of BHP. This drug has approximately a 100-fold greater affinity for type 2-5a-reductase than for type 1. In humans finasteride decreases prostatic DHT level and reduces prostate size, while T tissue concentration remains constant. 8) In this study, we determined the antiandrogenic activity of five new steroidal compounds: 4-8 in gonadectomized hamster seminal vesicles.
Seminal vesicles are male accessory glands that are androgen-dependent. These organs are capable of reducing T to DHT in both intact and gonadectomized animals and have also been used for evaluation of steroidal and non steroidal compounds as antiandrogens. 9, 10) Chemistry Several years ago we synthesized several new 17a-acyloyloxy-16b-methyl substituted pregnadiene-3,20-dione derivatives. 15, 16) Some of these compounds showed a high inhibitory effect for the enzyme 5a-reductase as well as high affinity for the androgen receptor. On the basis of these results and in order to expand the scope of this study, recently we synthesized several new 17a-acyloyloxy16b-substituted (methyl, bromine) pregnadiene-3,20-diones and pregnatriene-3,20-triones (4-8) which are described in this paper. Fig. 1 ) were prepared from the commercially available 16-dehydropregnenolone acetate (Fig. 2) . Epoxidation of the double bond at C-16 with hydrogen peroxide and sodium hydroxide afforded the epoxy derivative 9. The bromohydrin 10 was obtained when the intermediate 9 was treated with hydrobromic acid (32%) in dioxane for 6 h. When compound 10 was allowed to reflux with dichloro-dicyanobenzoquinone (DDQ) in dioxane for 4 d, the trienedione 4 was obtained. Esterification of the hydroxyl group in 4 with trifluoroacetic anhydride, p-toluenesulfonic acid and cyclopentanecarboxylic acid yielded the desired ester 5.
Synthesis of Steroids 4-8 Compounds 4-8 (
Compounds 6-8 ( Fig. 1) were prepared from the epoxy derivative 9 (Fig. 3) . Acetylation of 9 in the usual manner yielded the acetoxy compound 11. The protection of the carbonyl group in 11 was effected with ethylene glycol, trimethyl orthoformate and p-toluenesulfonic acid (PTSA). The resulting dioxolane derivative 12 was allowed to reflux with methylmagnesium chloride in tetrahydrofuran (THF); this reaction afforded the 16-methyl substituted dioxolane derivative 13. Hydrolysis of the dioxolane ring in 13 to recover the carbonyl moiety was carried out with PTSA in acetone thus forming the carbonyl derivative 14. The oxidation of the hydroxyl group at C-3 in 14 was effected with lithium carbonate, lithium bromide and bromine in N,N-dimethylformamide (DMF Biological Activity The biological activity of steroids 4 to 8 were determined in gonadectomized male hamsters divided in several groups. The animals in the control group were injected with the vehicle (sesame oil); in the other groups they were treated with T, 11) a combination of T with finasteride or T with the new steroids. After 6 d of treatment, the animals were anesthetized with ether and sacrificed. The seminal vesicles were removed weighed, homogenized and used for the in vitro experiments.
Seminal Vesicles After castration the weight of the seminal vesicles of the male hamsters significantly decreased (pϽ0.05) as compared to that of the normal glands. Treatment with vehicle alone (control) did not change this condition whereas subcutaneous injections of 200 mg of 1 for 6 d significantly increased (pϽ0.05) the weight of the seminal vesicles in castrated male hamsters (141.7 mg) ( Table 1) . When 1 and finasteride 3 were injected together, the weight of the seminal vesicles decreased (120 mg). The injection of steroids 6 and 7 together with T decreased the weight of the seminal vesicles as compared to the T treated hamsters thus suggesting an inhibitory effect on 5a-reductase enzyme type 2. The most effective compounds showing the highest inhibitory effect for 5a-reductase enzyme were steroids 6 and 7 having the lowest value of the weight of the seminal vesicles, 118 and 115 mg respectively.
In Vitro Metabolism of T to DHT Since the weight of the seminal vesicles depends on the 5a-reduced androgens, 1, 12, 13) it was important to determine the effect of the new steroids 4-8 on the conversion of 1 to 2 in vitro metabolism of [ Compound 7 which is structurally very similar to steroid 6 (one carbon atom less) showed a higher in vitro conversion of 1 to 2 (pϽ0.05) than steroids 3, 5, 6 and 8 however it still can be considered a 5a-reductase inhibitor due to the lower production of DHT as compared to testosterone. The weight of seminal vesicles were measured from animals that received sc treatment of C-16 substituted steroids. 
Scatchard Analysis of Receptor Androgen Binding

Discussion
This study reports the 5a-reductase inhibitory activity and the antiandrogenic effect of novel 16-bromo substituted trienediones 4, 5, the 16b methyl substituted dienediones 6, 7 and the trienedione 8 ( Fig. 1 ). Compound 4 (Fig. 4) did not decrease the weight of the seminal vesicles and did not inhibit the conversion of T to DHT (it has a weak androgenic effect) however it competed for the ARs (K i 45.38 nM). On the other hand, steroids 5, 6 and 8 showed a 5a-reductase inhibitory effect slightly higher than the commercially available finasteride 3 presently used for the treatment of benign prostatic hyperplasia however compounds 5 and 8 did not decrease the weight of the seminal vesicles compounds 5 and 6 did not show any affinity for the androgen receptor as indicated previously, however they strongly inhibited the enzyme 5a-reductase. Steroid 8 showed a slight affinity for the ARs, a moderate 5a-reductase inhibitory activity and did not decrease the weight of the seminal vesicles. Compound 7 which has a low inhibitory activity for the conversion of T to DHT and is structurally similar to 6 binds with a high affinity to the ARs and reduces the weight of the seminal vesicles, thus showing high antiandrogenic and also an inhibitory effect for the enzyme 5a-reductase.
In addition, we demonstrated that radio-inert DHT in increasing concentrations, inhibited the binding of [ 3 H]DHT to the ARs present in cytosolic fraction as shown by the K i value of 8.29 nM (Fig. 6) . Furthermore, some radio-inert synthetic steroids (4, 8, 7 ) also inhibited the binding of 
Experimental
Chemical and Radioactive Material Solvents were laboratory grade or better. Melting points were determined on a Fisher Johns melting point apparatus and are uncorrected. 
Synthesis of the Steroidal Compounds
The synthesis of the intermediates 9, 11-15 (Fig. 3) is given in refs. 15 and 16 . The preparation of the new compounds 4, 5, 10, 6-8 is briefly described below.
16b b-Bromo-17a a-hydroxypregna-1,4,6-triene-3,20-dione 4 A solution of steroid 10 (1 g, 2.43 mmol) and DDQ (1 g, 13.22 mmol) in dioxane (50 ml) was allowed to reflux for 3 d. Upon cooling, the precipitated 2,3-dichloro-5,6-dicyanohydroquinone was filtered off. To the filtrate was added 3% aqueous sodium hydroxide solution (100 ml) and chloroform (100 ml); the mixture was stirred for 5 min. The organic phase was separated, washed 3 times with 3% aqueous sodium hydroxide solution and water. It was dried over anhydrous sodium sulfate and the solvent was removed in vacuum. The crude product was purified by silica gel column chromatography. . 16b b-Bromo-17a a-cyclopentylacetoxy-1,4,6-pregnatriene-3,20-dione 5 A solution containing steroid 4 (1 g, 2.47 mmol), PTSA (100 mg), trifluoroacetic anhydride (2 ml, 9.53 mmol) and cyclopentylacetic acid (0.8 ml, 4.99 mmol) was stirred for 2 h at room temperature (nitrogen atmosphere). The reaction mixture was neutralized with an aqueous sodium bicarbonate solution to a pH of 7 and diluted with chloroform (10 ml). The organic phase was separated, washed with water and dried over anhydrous sodium sulfate; the solvent was eliminated in vacuum. The crude product was purified by silica gel column chromatography. Hexane-ethyl acetate (8 : 2) eluted 369 mg, 0.74 mmol (30%) of the pure product 5, mp 134-136°C. UV (nm) 217, 253, 291 (eϭ14600, 12400, 17500 respectively). IR (KBr) cm Ϫ1 : 1731, 1710, 1656, 1603. 04 mmol) and cyclopentylacetic acid (1.2 ml, 8.7 mmol) was stirred for 2 h at room temperature (nitrogen atmosphere). The reaction mixture was neutralized with an aqueous sodium bicarbonate solution to pH of 7 and diluted with chloroform (10 ml). The organic phase was separated, washed with water and drier over sodium sulfate; the solvent was eliminated in vacuum. The crude product was purified by silica gel column chromatography. Hexane-ethyl acetate (8 : 2) eluted 850 mg, 1.74 mmol (62%) of pure product 6, mp 182-183°C. UV (nm) 283 (eϭ22900). IR (KBr) cm (1.0 ml, 8.7 mmol) was stirred for 2 h at room temperature (nitrogen atmosphere). The reaction mixture was neutralized with an aqueous sodium bicarbonate solution to a pH of 7 and diluted with chloroform (10 ml). The organic phase was separated, washed with water and drier over anhydrous sodium sulfate; the solvent was eliminated in vacuum. The crude product was purified by silica gel column chromatography. Hexane-ethyl acetate (8 : 2) eluted 674 mg, 1.54 mmol (69%) of pure product 7, mp 160-165°C. UV (nm) 284 (eϭ23100 8 (3H, s), 1.1 (3H, s), 1.4 (3H, d, Jϭ2 Hz), 1.98 (3H, s), 5.8  (1H, s), 6.1 (2H, d, Jϭ3 Hz) . 13 1 g, 2. 21 mmol) and DDQ (2.21 g, 26.44 mmol) in dioxane (90 ml) was allowed to reflux for 2 d. Upon cooling, the precipitated 2,3-dichloro-5,6-dicyanohydroquinone was filtered off. To the filtrate was added 3% aqueous sodium hydroxide solution (100 ml) and chloroform (100 ml); the mixture was stirred for 5 min. The organic phase was separated, washed 3 times with 3% aqueous sodium hydroxide solution and water. It was dried over anhydrous sodium sulfate and the solvent was removed in vacuum. The crude product was purified by silica gel column chromatography. Hexane-ethyl acetate (6 : 4) eluted 850 mg, 1.74 mmol (70%) of pure product 8, mp 163-164°C. UV (nm) 222, 256, 299 (eϭ15200, 13000, 18000 respectively). IR (KBr) cm Animal Treatment The biological activity of steroids 4 to 8 ( Fig. 1 ) were determined in gonadectomized male hamsters divided in several groups. Daily subcutaneous injections of 400 mg of the steroids 4-8 ( Fig. 1 ) dissolved in 200 ml of sesame oil were administered for 6 d together with 200 mg of T. Three groups of animals were kept as a control, one was injected with 200 ml of sesame oil, the second with 200 mg of testosterone and the third with T together with finasteride for 6 d. After the treatment, the animals were sacrificed by ether anesthesia and the seminal vesicles were dissected and weighed.
In Vitro Metabolic Studies with Seminal Vesicles Homogenates from male hamster seminal vesicles (35.34 mg of protein) were prepared from intact adult male animals, using Krebs-Ringer phosphate buffer solution at pH of 6. Tissue preparations were incubated 11) in duplicate with 3.4 mCi of [ 3 H]T (specific activity 95 Ci/mmol) in the presence of 0.5 mM NADPH ϩ and 12.5 mM glucose-6-phosphate plus 0.8ϫ10 Ϫ6 g of glucose-6-phosphate dehydrogenase 1) and 8.7 mM of finasteride or steroids 4-8 in a Dubnoff metabolic incubator at 37°C for 60 min in the presence of air. The final incubation volume was 3 ml. The same experiment was performed with each one of the new steroidal compounds. Incubation without tissues was used as a control. The incubation was terminated by addition of dichloromethane and the [ 3 H] steroid was extracted (4ϫ) using 10 ml of dichloromethane. The protein content of the homogenates was determined by Bradford's dyebinding method 12) using bovine serum albumin (BSA) as the standard. Isolation and purity assessment of radioactive DHT was carried out. The isolated compound was purified with steroid carriers (T and DHT) by a thin layer chromatographic system (chloroform : acetoneϭ9 : 1). The steroid carriers were detected using phosphomolibdic acid reagent and an ultraviolet lamp (254 nm). Radioactivity was determined in a Packard Tri carb 2100 TR liquid scintillation Analyzer, using Ultima Gold (Packard Downers Grove, IL) as counting vehicle. The counting efficiency of [ 3 H] was 67%. The losses of radioactivity during the procedure were calculated in agreement with the results obtained from the control experiment without tissue. The formation of DHT was calculated and expressed as fmol of DHT/mg protein/h.
Cytosol Preparation for Androgen Receptor Competition Analysis
Tissue homogenization was performed as described above 12) using TEDAM 1:3 20 mM Tris-HCl, pH 7.4 at 4°C, 1.5 mM EDTA, 0.25 mM dithiothreitol, and 10 mM sodium molibdate containing 10% glycerol (v/v). The homogenate was centrifuged at 140000ϫg for 1 h at 4°C in a SW 60 Ti rotor (Beckman Instruments, Palo Alto, California). Cytosol protein content was determined by Bradford's dye binding method 12) using bovine serum albumin (BSA) as the standard.
Androgen Receptor Binding Assay Assays were performed essentially as described by Cabeza et al.
13)
Saturation Curves and Determination of the Binding Parameters
Binding sites were saturated in the presence of increasing concentrations (0.5-2.5) of [ 3 H]DHT. Results were analyzed with Scatchard plots, 14) the calculation of affinity (K d ) and the total number of sites (B max ) were determined by linear regression.
Aliquots of 120 ml of cytosol (2.64 mg of protein) were incubated (in duplicate) for 18-20 h at 4°C in tubes containing 0.5-2.5 nM [
3 H]DHT. Parallel sets of tubes containing identical concentrations of [ 3 H]DHT plus 100-fold excess of radioinert DHT were also incubated. Dextran coated charcoal (800 ml) in TEDAM buffer was added and the mixture was incubated for 45 min at 4°C. The tubes were vortexed and immediately centrifuged at 800ϫg for 10 min.
Competition Analysis of Synthesized Steroids for ARs
The competition analysis of steroids 4-8 for the androgen receptors of castrated male hamster seminal vesicles was determined on 58 animals (150-200 g), selected at random and gonadectomized 30 d before the experiments. The animals were kept in a room with controlled temperature (22°C) and light-dark periods of 12 h. Food and water were provided ad libitum.
Androgen receptor competition studies were performed essentially as described by Cabeza et al. 13) and are briefly summarized below. Competition Studies For competition experiments, tubes contained 1.26 nM [ 3 H]DHT (specific activity 110 Ci/mmol) plus a range of increasing concentrations (50-500 mM) of the following unlabeled steroid hormones: 5-a DHT, and 4-8 were prepared.
Aliquots 120 ml of cytosol (2.64 mg of protein) were added and incubated (in duplicate) for 18-20 h at 4°C in tubes mentioned above. Parallel sets of tubes containing identical concentrations of [ 3 H]DHT plus a 100-fold excess of radio inert DHT were also incubated; 800 ml of dextran-coated charcoal in TEDAM buffer was added and the mixture was incubated for 45 min at 4°C. The dextran was agitated during 30 min before the addition of charcoal to the mixture. The tubes were vortexed and incubated for 45 min at 4°C. After the tubes were centrifuged at 800ϫg for 10 min; aliquot (200 ml) were subsequently submitted to radioactive counting. Specific binding was determined by subtracting the mean disintegration per minute (dpm) in the presence of excess unlabeled steroids from the mean dpm of corresponding tubes containing only [ 3 H]DHT. Results were analyzed using one-way analysis of variance with EPISTAT software. The inhibition constant (K i ) of each compound was calculated according to the procedures described by Cheng and Prusoff. 17) 
